ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹4082 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.35 | 1.94 |
| Manager | Rohan Korde | Pradeep Kesavan |
| ISIN Code | INF00XX01BL5 | INF200K01446 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | -2.47% | -1.23% |
| 6 Month | -0.27% | 3.08% |
| 1 Year | -7.44% | -0.09% |
| 3 Year | 18.31% | 23.42% |
| 5 Year | - | 17.78% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | -0.69% | 1.08% |
| 1 Year | 2.04% | 7.72% |
| 3 Year | 15.81% | 20.98% |
| 5 Year | - | 19.83% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 18.94% | 15.37% |
| 3 Year | 20.21% | 18% |
| 5 Year | - | 13.25% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | 15.64% | 14.02% |
| Sharp | 0.77% | 1.23% |
| Beta | 0.95% | 0.8% |
| Alpha | -2.74% | 5.73% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Rohan Korde | Pradeep Kesavan |
| Total AUM | ₹4626 Cr | ₹434274 Cr |
| Funds Managed | 10 | 43 |
| ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 3.94 | 8 |
| Large Cap | 32.04 | 39.15 |
| Mid Cap | 36.31 | 19.53 |
| Small Cap | 27.72 | 33.32 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.7 | 8 |
| Healthcare | 93.14 | - |
| Basic Materials | 2.87 | - |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | - |
| Pharmaceuticals & Biotechnology | - | 64.15 |
| Healthcare Services | - | 21.4 |
| Chemicals & Petrochemicals | - | 2.58 |
| Healthcare Equipment & Supplies | - | 2.94 |
| Retailing | - | 0.93 |
Top Comparisons
ICICI Prudential Floating Interest Fund - Growth
3Y Returns7.85%
SBI Floating Rate Debt Fund - Regular Plan - Growth
3Y Returns7.7%
HSBC ELSS Tax saver Fund - Regular Growth
3Y Returns18.43%
DSP ELSS Tax Saver Fund - Regular Plan - Growth
3Y Returns18.79%
HDFC Large Cap Fund - Growth Option - Regular Plan
3Y Returns15.01%
Sundaram Large Cap Fund Regular Plan - Growth
3Y Returns11.18%
Edelweiss Multi Cap Fund - Regular (G)
3Y Returns0%
Mirae Asset Multicap Fund - Regular (G)
3Y Returns0%